CLINICAL_TRIALS
trial_result
· 2020-05-28
Clinical Trial Update: Bioequivalence of Ethylenediamine Dihydrochloride Study [Phase 4]
Summary
A Phase 4 trial update reports bioequivalence testing for Ethylenediamine Dihydrochloride in Allergic Contact Dermatitis; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allerderm | Conditions: Allergic Contact Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2020-05-28